PUBLISHER: Grand View Research | PRODUCT CODE: 1321419
PUBLISHER: Grand View Research | PRODUCT CODE: 1321419
The global brachioplasty market size is expected to reach USD 2.32 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 7.1% from 2023 to 2030. The primary factors driving the growth are the increasing weight-loss surgeries across developed regions, a growing correlation between self-esteem and obesity, and technological advancements in non-surgical techniques.
According to the American Society for Metabolic and Bariatric Surgery, 256,000 weight loss surgeries were performed in the U.S. in 2019. Additionally, rising technological advancements in non-surgical procedures for brachioplasty will offer additional benefits compared to surgical procedures. For instance, in March 2023, Sentient, LLC received product approval from the U.S. FDA for its Sentient Sculpt, a non-invasive electromagnetic wave treatment for cellulite reduction.
Moreover, different types of medical literature are being recognized, propelling the safety of weight-loss surgeries in the geriatric population. The senior population would reach an estimated 71 million by 2030 in the U.S., from the current 54.1 million in 2022. Players operating in the market can readily target this demographic,
COVID-19 negatively impacted the brachioplasty industry as various elective surgical procedures were halted, and beds were assigned to COVID-19 patients. According to the American Society of Plastic Surgeons, brachioplasty procedures in the U.S. decreased by 17% in 2020. However, the market recovered from the pandemic losses in 2021. According to the National Institute of Health article, cosmetic and aesthetic procedures increased by 29.7% in 2021 from 2019.